FREMONT, Calif., April 16, 2012 /PRNewswire/ -- WaferGen Bio-systems, Inc.

Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer.

Upcoming webinar showcases a new genotyping-by-sequencing (GBS) method enabled by Innovadyne Liquid Handler. (PRWEB) December 27, 2011 In cooperation

Roche NimbleGen, Inc. and BGI, the world's largest genomics organization, announced that they have developed a Major Histocompatibility Complex (MHC) region capture technology based on NimbleGen SeqCap EZ Choice Library, a revolutionary process for the enrichment of the MHC region.

SHENZHEN, China, November 28, 2011 /PRNewswire/ -- Roche NimbleGen, Inc.